Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Humanized GPIbα-von Willebrand factor interaction in the mouse.

Kanaji S, Orje JN, Kanaji T, Kamikubo Y, Morodomi Y, Chen Y, Zarpellon A, Eberhardt J, Forli S, Fahs SA, Sood R, Haberichter SL, Montgomery RR, Ruggeri ZM.

Blood Adv. 2018 Oct 9;2(19):2522-2532. doi: 10.1182/bloodadvances.2018023507.

2.

miR-3148 Is a Novel Onco-microRNA that Potentiates Tumor Growth In Vivo.

Akamine T, Morodomi Y, Harada Y, Teraishi K, Tagawa T, Okamoto T, Maehara Y, Yonemitsu Y.

Anticancer Res. 2018 Oct;38(10):5693-5701. doi: 10.21873/anticanres.12906.

PMID:
30275189
3.

Tyrosyl-tRNA synthetase stimulates thrombopoietin-independent hematopoiesis accelerating recovery from thrombocytopenia.

Kanaji T, Vo MN, Kanaji S, Zarpellon A, Shapiro R, Morodomi Y, Yuzuriha A, Eto K, Belani R, Do MH, Yang XL, Ruggeri ZM, Schimmel P.

Proc Natl Acad Sci U S A. 2018 Aug 28;115(35):E8228-E8235. doi: 10.1073/pnas.1807000115. Epub 2018 Aug 13.

4.

Monitoring trifluridine incorporation in the peripheral blood mononuclear cells of colorectal cancer patients under trifluridine/tipiracil medication.

Nakanishi R, Kitao H, Kiniwa M, Morodomi Y, Iimori M, Kurashige J, Sugiyama M, Nakashima Y, Saeki H, Oki E, Maehara Y.

Sci Rep. 2017 Dec 5;7(1):16969. doi: 10.1038/s41598-017-17282-5.

5.

Reply to "EGFR Mutation in Patients with Lung Adenosquamous Cell Carcinoma".

Morodomi Y, Okamoto T, Maehara Y.

Ann Surg Oncol. 2017 Dec;24(Suppl 3):676. doi: 10.1245/s10434-017-6181-z. Epub 2017 Oct 27. No abstract available.

PMID:
29079921
6.

Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.

Katsura M, Shoji F, Okamoto T, Shimamatsu S, Hirai F, Toyokawa G, Morodomi Y, Tagawa T, Oda Y, Maehara Y.

Cancer Sci. 2018 Jan;109(1):154-165. doi: 10.1111/cas.13422. Epub 2017 Nov 9.

7.

Clinical Significance of DNA Damage Response Factors and Chromosomal Instability in Primary Lung Adenocarcinoma.

Okamoto T, Kohno M, Ito K, Takada K, Katsura M, Morodomi Y, Toyokawa G, Shoji F, Maehara Y.

Anticancer Res. 2017 Apr;37(4):1729-1735.

PMID:
28373435
8.

Clinical Evaluation and Outcomes of Digital Chest Drainage after Lung Resection.

Shoji F, Takamori S, Akamine T, Toyokawa G, Morodomi Y, Okamoto T, Maehara Y.

Ann Thorac Cardiovasc Surg. 2016 Dec 20;22(6):354-358. doi: 10.5761/atcs.oa.16-00179. Epub 2016 Nov 23.

9.

Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.

Suzuki Y, Okamoto T, Fujishita T, Katsura M, Akamine T, Takamori S, Morodomi Y, Tagawa T, Shoji F, Maehara Y.

Lung Cancer. 2016 Nov;101:92-97. doi: 10.1016/j.lungcan.2016.08.007. Epub 2016 Aug 16.

PMID:
27794415
10.

Clinical Significance of PD-L1 Protein Expression in Surgically Resected Primary Lung Adenocarcinoma.

Takada K, Okamoto T, Shoji F, Shimokawa M, Akamine T, Takamori S, Katsura M, Suzuki Y, Fujishita T, Toyokawa G, Morodomi Y, Okano S, Oda Y, Maehara Y.

J Thorac Oncol. 2016 Nov;11(11):1879-1890. doi: 10.1016/j.jtho.2016.06.006. Epub 2016 Jun 23.

11.

A novel method of using bioabsorbable materials for the surgical repair of flail chest.

Morodomi Y, Okamoto T, Tagawa T, Shoji F, Katsura M, Fujishita T, Fujiyoshi T, Akahoshi T, Yasuda M, Maehara Y.

J Trauma Acute Care Surg. 2016 Nov;81(5):984-987. No abstract available.

PMID:
27602896
12.

Prognostic Significance of Expression of the Epithelial-Mesenchymal Transition-Related Factor Brachyury in Intrathoracic Lymphatic Spread of Non-Small Cell Lung Cancer.

Shimamatsu S, Okamoto T, Haro A, Kitahara H, Kohno M, Morodomi Y, Tagawa T, Okano S, Oda Y, Maehara Y.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):1012-1020. Epub 2016 Sep 6.

PMID:
27600618
13.

Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.

Shoji F, Morodomi Y, Akamine T, Takamori S, Katsura M, Takada K, Suzuki Y, Fujishita T, Okamoto T, Maehara Y.

Lung Cancer. 2016 Aug;98:15-21. doi: 10.1016/j.lungcan.2016.05.010. Epub 2016 May 16.

PMID:
27393501
14.

Case of a Cardiopulmonary Arrest Due to Postoperative Subglottic Stenosis Developed on the Second Day after Lung Surgery.

Shimagaki T, Okamoto T, Morodomi Y, Shoji F, Akamine T, Takamori S, Katsura M, Takada K, Suzuki Y, Fujishita T, Hayamizu K, Tokuda K, Yasuda M, Maehara Y.

Fukuoka Igaku Zasshi. 2016 Jul;107(7):136-40. Japanese.

PMID:
29226664
15.

Prognostic Impact of EGFR Driver Mutations on Postoperative Disease Recurrence in Lung Adenocarcinoma.

Okamoto T, Kitahara H, Shimamatsu S, Katsura M, Takada K, Fujishita T, Suzuki Y, Morodomi Y, Tagawa T, Maehara Y.

Anticancer Res. 2016 Jun;36(6):3057-63.

PMID:
27272827
16.

The antibodies against 5-bromo-2'-deoxyuridine specifically recognize trifluridine incorporated into DNA.

Kitao H, Morodomi Y, Niimi S, Kiniwa M, Shigeno K, Matsuoka K, Kataoka Y, Iimori M, Tokunaga E, Saeki H, Oki E, Maehara Y.

Sci Rep. 2016 May 3;6:25286. doi: 10.1038/srep25286.

17.

Nanomedicines Eradicating Cancer Stem-like Cells in Vivo by pH-Triggered Intracellular Cooperative Action of Loaded Drugs.

Kinoh H, Miura Y, Chida T, Liu X, Mizuno K, Fukushima S, Morodomi Y, Nishiyama N, Cabral H, Kataoka K.

ACS Nano. 2016 Jun 28;10(6):5643-55. doi: 10.1021/acsnano.6b00900. Epub 2016 Apr 25.

18.

PD-L1 Is Upregulated by Simultaneous Amplification of the PD-L1 and JAK2 Genes in Non-Small Cell Lung Cancer.

Ikeda S, Okamoto T, Okano S, Umemoto Y, Tagawa T, Morodomi Y, Kohno M, Shimamatsu S, Kitahara H, Suzuki Y, Fujishita T, Maehara Y.

J Thorac Oncol. 2016 Jan;11(1):62-71. doi: 10.1016/j.jtho.2015.09.010.

19.

Peritoneal Dissemination Requires an Sp1-Dependent CXCR4/CXCL12 Signaling Axis and Extracellular Matrix-Directed Spheroid Formation.

Kasagi Y, Harada Y, Morodomi Y, Iwai T, Saito S, Yoshida K, Oki E, Saeki H, Ohgaki K, Sugiyama M, Onimaru M, Maehara Y, Yonemitsu Y.

Cancer Res. 2016 Jan 15;76(2):347-57. doi: 10.1158/0008-5472.CAN-15-1563. Epub 2016 Jan 7.

20.

Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy.

Tagawa T, Anraku M, Morodomi Y, Takenaka T, Okamoto T, Takenoyama M, Ichinose Y, Maehara Y, Cho BC, Feld R, Tsao MS, Leighl N, Bezjak A, Keshavjee S, de Perrot M.

J Thorac Dis. 2015 Nov;7(11):1898-906. doi: 10.3978/j.issn.2072-1439.2015.11.15. Erratum in: J Thorac Dis. 2016 Jan;8(1):E161.

21.

Underlying Problems in Surgical Treatment of cT1-2N1 Non-Small Cell Lung Cancer.

Okamoto T, Tagawa T, Morodomi Y, Shimamatsu S, Kitahara H, Maehara Y.

Thorac Cardiovasc Surg. 2017 Mar;65(2):130-135. doi: 10.1055/s-0035-1558648. Epub 2015 Aug 10.

PMID:
26258472
22.

Liver transplantation followed by pulmonary resection complicated with end-stage liver cirrhosis: a case report.

Taniguchi D, Harimoto N, Takeishi K, Itoh S, Yamashita Y, Ikegami T, Yoshizumi T, Kawanaka H, Shirabe K, Morodomi Y, Tagawa T, Okamoto T, Maehara Y.

Anticancer Res. 2015 Jun;35(6):3411-4.

PMID:
26026103
23.

Associations between driver gene mutations and cytotoxic chemosensitivity in patients with non-small cell lung cancer.

Morodomi Y, Okamoto T, Kohno M, Katsura M, Takada K, Suzuki Y, Fujishita T, Kitahara H, Shimamatsu S, Yoshida T, Tagawa T, Okano S, Maehara Y.

Anticancer Res. 2015 Mar;35(3):1791-6.

PMID:
25750344
24.

Applicability of Pulmonary Lobectomy in Treating Metastatic Lung Tumors.

Okamoto T, Kitahara H, Shimamatsu S, Morodomi Y, Tagawa T, Maehara Y.

Ann Thorac Cardiovasc Surg. 2015;21(3):189-93. doi: 10.5761/atcs.oa.14-00183. Epub 2015 Jan 26.

25.

Clinical Significance of Detecting Somatic Gene Mutations in Surgically Resected Adenosquamous Cell Carcinoma of the Lung in Japanese Patients.

Morodomi Y, Okamoto T, Takenoyama M, Takada K, Katsura M, Suzuki Y, Fujishita T, Kitahara H, Shimamatsu S, Kohno M, Tagawa T, Okano S, Taguchi K, Ichinose Y, Maehara Y.

Ann Surg Oncol. 2015 Aug;22(8):2593-8. doi: 10.1245/s10434-014-4218-0. Epub 2014 Nov 6.

PMID:
25373537
26.

Successful resection of a giant mediastinal non-seminomatous germ cell tumor showing fluorodeoxyglucose accumulation after neoadjuvant chemotherapy: report of a case.

Takada K, Morodomi Y, Okamoto T, Suzuki Y, Fujishita T, Kitahara H, Shimamatsu S, Kohno M, Kawano D, Hidaka N, Nakanishi Y, Maehara Y.

Fukuoka Igaku Zasshi. 2014 May;105(5):117-23.

PMID:
25283008
27.

A rare case of a bronchial anomaly running in the hilar region from the right lower lobe to the middle lobe.

Fujishita T, Okamoto T, Suzuki Y, Kitahara H, Shimamatsu S, Kohno M, Morodomi Y, Kawano D, Matsuo Y, Honda H, Maehara Y.

Fukuoka Igaku Zasshi. 2014 Apr;105(4):100-4.

PMID:
25076781
28.

[Case of pulmonary inflammatory pseudotumor with cysts].

Katsura M, Kitahara H, Morodomi Y, Kawano D, Koga T, Furuta T, Okamoto T, Oda Y, Maehara Y.

Fukuoka Igaku Zasshi. 2014 Mar;105(3):74-8. Japanese.

PMID:
25000659
29.

Non-small cell lung cancer patients with EML4-ALK fusion gene are insensitive to cytotoxic chemotherapy.

Morodomi Y, Takenoyama M, Inamasu E, Toyozawa R, Kojo M, Toyokawa G, Shiraishi Y, Takenaka T, Hirai F, Yamaguchi M, Taguchi K, Seto T, Sugio K, Ichinose Y.

Anticancer Res. 2014 Jul;34(7):3825-30.

PMID:
24982409
30.

The prognostic impact of the amount of tobacco smoking in non-small cell lung cancer--differences between adenocarcinoma and squamous cell carcinoma.

Okamoto T, Suzuki Y, Fujishita T, Kitahara H, Shimamatsu S, Kohno M, Morodomi Y, Kawano D, Maehara Y.

Lung Cancer. 2014 Aug;85(2):125-30. doi: 10.1016/j.lungcan.2014.06.006. Epub 2014 Jun 16.

PMID:
24976334
31.

Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.

Takenaka T, Takenoyama M, Yamaguchi M, Toyozawa R, Inamasu E, Kojo M, Toyokawa G, Yoshida T, Shiraishi Y, Morodomi Y, Hirai F, Taguchi K, Shimokawa M, Seto T, Ichinose Y.

Eur J Cardiothorac Surg. 2015 Mar;47(3):550-5. doi: 10.1093/ejcts/ezu227. Epub 2014 Jun 3.

PMID:
24894095
32.

[A case of surgical treatment for a bilateral pneumothorax that occurred in a patient with severe asbestosis and advanced emphysema].

Kurihara T, Kawano D, Okamoto T, Fujishita T, Suzuki Y, Kitahara H, Shimamatsu S, Kouno M, Morodomi Y, Maehara Y.

Fukuoka Igaku Zasshi. 2014 Jan;105(1):28-31. Japanese.

PMID:
24800531
33.

Application of continuous negative pressure irrigation and negative pressure fixation to treat a bronchopleural fistula with thoracic empyema.

Morodomi Y, Takenoyama M, Yamaguchi M, Inamasu E, Yoshida T, Kawano D, Okamoto T, Inoue Y, Maehara Y, Ichinose Y.

J Am Coll Surg. 2014 May;218(5):e87-90. doi: 10.1016/j.jamcollsurg.2013.12.053. Epub 2014 Feb 19. No abstract available.

PMID:
24745581
34.

[Case of adenocarcinoma in situ accompanied by an intrapulmonary lymph node with a sarcoid-like reaction].

Kawano D, Okamoto T, Morodomi Y, Kono M, Shimamatsu S, Kitahara H, Kawasaki J, Miyazaki M, Yamagata M, Sonoda T.

Fukuoka Igaku Zasshi. 2013 Oct;104(10):394-6. Japanese.

PMID:
24511672
35.

Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.

Toyokawa G, Takenoyama M, Hirai F, Toyozawa R, Inamasu E, Kojo M, Morodomi Y, Shiraishi Y, Takenaka T, Yamaguchi M, Shimokawa M, Seto T, Ichinose Y.

Int J Clin Oncol. 2014 Aug;19(4):601-6. doi: 10.1007/s10147-013-0619-5. Epub 2013 Oct 26.

PMID:
24158772
36.

Dramatic response to crizotinib in an ALK-positive adenocarcinoma patient with disseminated intravascular coagulation.

Toyokawa G, Takenoyama M, Watanabe S, Toyozawa R, Inamasu E, Kojo M, Shiraishi Y, Morodomi Y, Takenaka T, Hirai F, Yamaguchi M, Taguchi K, Seto T, Ichinose Y.

J Thorac Oncol. 2013 Nov;8(11):e96-8. doi: 10.1097/JTO.0b013e3182a008ed. No abstract available.

37.

Recurrence of thymic neuroendocrine carcinoma 24 years after total excision: A case report.

Toyokawa G, Taguchi K, Kojo M, Toyozawa R, Inamasu E, Morodomi Y, Shiraishi Y, Takenaka T, Hirai F, Yamaguchi M, Seto T, Takenoyama M, Ichinose Y.

Oncol Lett. 2013 Jul;6(1):147-149. Epub 2013 May 1.

38.

Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.

Hirai F, Seto T, Yamanaka T, Toyozawa R, Inamasu E, Kojo M, Toyokawa G, Morodomi Y, Shiraishi Y, Takenaka T, Yamaguchi M, Takenoyama M, Ichinose Y.

Jpn J Clin Oncol. 2013 Oct;43(10):1018-22. doi: 10.1093/jjco/hyt106. Epub 2013 Aug 4.

PMID:
23917962
39.

The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene.

Toyokawa G, Takenoyama M, Taguchi K, Arakaki K, Inamasu E, Toyozawa R, Kojo M, Shiraishi Y, Morodomi Y, Takenaka T, Hirai F, Yamaguchi M, Seto T, Leone A, Graziano P, Ichinose Y.

Lung Cancer. 2013 Sep;81(3):491-4. doi: 10.1016/j.lungcan.2013.06.013. Epub 2013 Jul 26.

PMID:
23891513
40.

Ex vivo generation of highly purified and activated natural killer cells from human peripheral blood.

Saito S, Harada Y, Morodomi Y, Onimaru M, Yoshida K, Kyuragi R, Matsubara H, Yonemitsu Y.

Hum Gene Ther Methods. 2013 Aug;24(4):241-52. doi: 10.1089/hgtb.2012.183.

41.

An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene.

Toyokawa G, Takenoyama M, Taguchi K, Toyozawa R, Inamasu E, Kojo M, Shiraishi Y, Morodomi Y, Takenaka T, Hirai F, Yamaguchi M, Seto T, Shimokawa M, Ichinose Y.

Lung Cancer. 2013 Sep;81(3):487-90. doi: 10.1016/j.lungcan.2013.05.022. Epub 2013 Jun 17.

PMID:
23787064
42.

Clinico-pathological features and management of lung cancer patients with atherosclerotic vascular diseases.

Shoji F, Morodomi Y, Kyuragi R, Okamoto T, Matsumoto T, Yano T, Maehara Y.

Ann Thorac Cardiovasc Surg. 2013;19(5):345-50. Epub 2012 Dec 13.

43.

First case of combined small-cell lung cancer with adenocarcinoma harboring EML4-ALK fusion and an exon 19 EGFR mutation in each histological component.

Toyokawa G, Taguchi K, Ohba T, Morodomi Y, Takenaka T, Hirai F, Yamaguchi M, Seto T, Takenoyama M, Sugio K, Ichinose Y.

J Thorac Oncol. 2012 Dec;7(12):e39-e41. doi: 10.1097/JTO.0b013e3182762bcb. No abstract available.

44.

Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography.

Takenaka T, Yano T, Morodomi Y, Ito K, Miura N, Kawano D, Shoji F, Baba S, Abe K, Honda H, Maehara Y.

Surg Today. 2012 Oct;42(10):934-9. doi: 10.1007/s00595-012-0277-7. Epub 2012 Aug 3.

PMID:
22864936
45.

Serum antioxidant capacity and oxidative injury to pulmonary DNA in never-smokers with primary lung cancer.

Ito K, Yano T, Morodomi Y, Yoshida T, Kohno M, Haro A, Shikada Y, Okamoto T, Maruyama R, Maehara Y.

Anticancer Res. 2012 Mar;32(3):1063-7.

PMID:
22399633
46.

BioKnife, a uPA activity-dependent oncolytic Sendai virus, eliminates pleural spread of malignant mesothelioma via simultaneous stimulation of uPA expression.

Morodomi Y, Yano T, Kinoh H, Harada Y, Saito S, Kyuragi R, Yoshida K, Onimaru M, Shoji F, Yoshida T, Ito K, Shikada Y, Maruyama R, Hasegawa M, Maehara Y, Yonemitsu Y.

Mol Ther. 2012 Apr;20(4):769-77. doi: 10.1038/mt.2011.305. Epub 2012 Feb 7.

47.

Pericardial fat pad tissue produces angiogenic factors for healing the bronchial stump.

Shoji F, Yano T, Miura N, Morodomi Y, Yoshida T, Onimaru M, Maehara Y.

Interact Cardiovasc Thorac Surg. 2011 Sep;13(3):271-5. doi: 10.1510/icvts.2011.274480. Epub 2011 Jun 23.

PMID:
21700593
48.

The influence of intracellular epidermal growth factor receptor (EGFR) signal activation on the outcome of EGFR tyrosine kinase inhibitor treatment for pulmonary adenocarcinoma.

Kawano D, Yano T, Shoji F, Ito K, Morodomi Y, Haro A, Miura N, Takenaka T, Yoshino I, Maehara Y.

Surg Today. 2011 Jun;41(6):818-23. doi: 10.1007/s00595-011-4514-2. Epub 2011 May 28.

PMID:
21626329
49.

Assessing a clinical pathway to improve the quality of care in pulmonary resections.

Shoji F, Yano T, Haro A, Yoshida T, Ito K, Morodomi Y, Wakata Y, Maehara Y.

Surg Today. 2011 Jun;41(6):787-90. doi: 10.1007/s00595-010-4483-x. Epub 2011 May 28.

PMID:
21626323
50.

Effectiveness of erlotinib against recurrent pulmonary adenocarcinoma unresponsive to gefitinib: report of a case.

Shoji F, Kawano D, Ito K, Morodomi Y, Yano T, Maehara Y.

Surg Today. 2011 Feb;41(2):255-7. doi: 10.1007/s00595-009-4259-3. Epub 2011 Jan 26.

PMID:
21264764

Supplemental Content

Loading ...
Support Center